Multiple Sclerosis
-
Autoimmune diseases such as MS and rheumatoid arthritis affect almost four percent of the global population. A new study has now identified a naturally occurring compound that may provide a new way of treating these debilitating diseases.
-
Investigating ways to head off the chain of events that leads to multiple sclerosis, researchers have found a chemical regulator in mice that causes the inflammatory cascade associated with the disease. They also figured out how to switch it off.
-
It's often hard to see the forest from the trees but if we zoom out a little it becomes clear 2022 saw some incredible breakthroughs in the world of medical science. All of these stories are landmark moments that are set to shape the future of medicine.
-
The dysfunction of microglia in the central nervous system is linked to range of diseases, prompting a wide-ranging search for drugs that can alter their activity. New research, however, suggests we might already one such drug at our disposal.
-
Scientists may have uncovered a new therapy for multiple sclerosis, involving an inflammation-regulating lipid. Tests in mice showed that the lipid reduced symptoms and slowed disease progression, hinting at an underlying mechanism for the condition.
-
For decades those with multiple sclerosis have suggested dairy products can exacerbate their disease. Now researchers have shown how this could be occurring, by finding a protein in cow milk can trigger the immune cells known to damage neurons in MS.
-
Several new studies have shed light on links between diseases not previously thought to be related to viral infections, from a common childhood virus being linked to bladder cancer to an association between hepatitis C and schizophrenia.
-
Researchers have been studying saliva from ticks in hope of developing next-generation medications, and a new paper has demonstrated how proteins within it can be modified to take am at the underlying cause of inflammatory diseases in humans.
-
A study has reported evidence to affirm multiple sclerosis is caused by infection from the Epstein-Barr virus (EBV). Tracking 10 million subjects over 20 years, the findings indicate EBV infection leads to a 32-fold increased risk of developing MS.
-
Two new studies are building on a hypothesis that multiple sclerosis (MS) can be triggered by viral infections in a person’s teenage years. The research raises concerns the current COVID-19 pandemic could lead to a surge in MS cases in the future.
-
Scientists have made a promising discovery relating to MS, demonstrating how neutralizing a specific protein can selectively temper the inflammation that drives the disease, which makes it an ideal target in the ongoing pursuit of a cure.
-
Getting traditionally administered drugs into the brain can be challenging, due to the body's protective blood-brain barrier. There may be new hope, however, in the form of a patch that gets shoved up the patient's nose.
Load More